IINN

Inspira Technologies Oxy BHN Ltd
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$17.21M
P/E Ratio
EPS
$-0.45
Beta
2.16
52W High
$1.65
52W Low
$0.34
50-Day MA
$0.49
200-Day MA
$0.88
Dividend Yield
Profit Margin
0.00%
Forward P/E
4.26
PEG Ratio

About Inspira Technologies Oxy BHN Ltd

Inspira Technologies Oxy BHN Ltd., a specialty medical device company, is engaged in the research, development, manufacture and commercialization of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory insufficiency. The company is headquartered in Ra'annana, Israel.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)289,000
Gross Profit (TTM)2,000
EBITDA$-13.47M
Operating Margin-4714.00%
Return on Equity-397.90%
Return on Assets-127.00%
Revenue/Share (TTM)$0.01
Book Value$0.07
Price-to-Book7.99
Price-to-Sales (TTM)56.14
EV/Revenue54.95
EV/EBITDA-0.15
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$43.58M
Float$32.37M
% Insiders10.23%
% Institutions14.80%

Historical Volatility

HV 10-Day
132.44%
HV 20-Day
104.66%
HV 30-Day
122.95%
HV 60-Day
113.74%
HV Rank
79.0%

Volatility is currently expanding

Latest News

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

Nes Ziona, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure today announced that a U.S. Government lab conducting quantum computing programs is actively operating the Company's AME system. The operational use places the Company's technology inside a U.S. federal quantum and advanced-microelectronics development environment, providing the lab with direct access to the unique capabilities enabled by the Company's AME platform.

GlobeNewsWire7/6/2026Neutral
QTREX Engineers Conductivity Itself to Address Quantum Computing's Cryogenic Heat-Load Barrier

The Company Filed a U.S. Provisional Patent Application Covering a Potentially Dominant Approach to the Critical Cryogenic Signal Pathway, Designed to Overcome Limitations of Traditional Manufacturing The Company Filed a U.S. Provisional Patent Application Covering a Potentially Dominant Approach to the Critical Cryogenic Signal Pathway, Designed to Overcome Limitations of Traditional Manufacturing

GlobeNewsWire7/1/2026Neutral
QTREX Awarded Government Grant to Advance the World's First Native RF Dielectric Material for Quantum Computing

Nes Ziona, June 09, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure, today announced that the Israel Innovation Authority (“IIA”) has awarded the Company an approximately $1 million grant to support the development of a purpose-built dielectric material engineered for high-density, low-loss RF signal routing in scalable superconducting quantum computing systems.

GlobeNewsWire6/9/2026Neutral
QTREX to Showcase Functional AME-Based Monolithic Connectivity Components for Quantum Computing Systems at Quantum.Tech World 2026 in Boston

Nes Ziona, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure, today announced that Mr. Tal Parnas, Chairman of the Company's Board of Directors, and Mr. Yoav Rozanovich, the Company's Chief Business Officer, will be in Boston, Massachusetts during Quantum.Tech World 2026 on June 25–26, 2026, to present functional AME-based monolithic connectivity components engineered for quantum computing systems.

GlobeNewsWire6/2/2026Neutral
QTREX Secures Purchase Order from a U.S.-based Fortune 500 company for an AME System and Related Materials

Nes Ziona, Israel, June 01, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics (“AME”) for quantum computing infrastructure, today announced that it received a purchase order from a Fortune 500 multinational company for an AME system and related materials. The customer is headquartered in the United States, and the AME system will be delivered to one of the customer's sites outside the United States.

GlobeNewsWire6/1/2026Neutral
QTREX in Advanced Discussions with Top-Five Global Quantum Computing Company Regarding Strategic Collaboration

Nes Ziona, Israel, May 21, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a developer of additively manufactured electronics ("AME") technologies for cryogenic interconnect and quantum hardware infrastructure, today announced that it is in advanced discussions with one of the top five companies globally in quantum computing systems regarding a strategic collaboration agreement.

GlobeNewsWire5/21/2026Neutral
Inspira Technologies to Begin Trading as QTREX Quantum Under Nasdaq Ticker "QTEX" on May 20, 2026, Following Strategic Focus on AME and Quantum Connectivity

RA'ANANA, Israel, May 19, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that, at the opening of trading on the Nasdaq Capital Market on May 20, 2026, the Company's ordinary shares will begin trading under the new ticker symbol "QTEX" in connection with the Company's corporate name change to QTREX Quantum Ltd.

GlobeNewsWire5/19/2026Neutral
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

RA'ANANA, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that it has received a $580,000 commercial purchase order from NYU Langone Hospital in New York City (“NYU Langone”) for the Company's FDA-cleared ART100 extracorporeal blood circulation systems. The order was placed through Inspira's U.S. distributor following the successful completion of a multi-patient clinical evaluation at the hospital, and the systems are scheduled for immediate fulfillment. This commercial milestone is in parallel with the Company's previously disclosed active strategic process involving the ART100 platform and broader medical assets.

GlobeNewsWire5/18/2026Neutral
Inspira Secures $596,000 AME System Order from Leading Irish Technological University

RA'ANANA, Israel, May 01, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IINNW) ("Inspira" or the "Company") today announced that it has secured a $596,000 purchase order for an Additively Manufactured Electronics ("AME") system from a leading Irish technological research university. The order is structured with a non-refundable upfront payment of 40% of the order value, which has been received by the Company, with the balance payable against delivery.

GlobeNewsWire5/1/2026Neutral

More HEALTHCARE Stocks

Data last updated: 5/20/2026